Jaye Thompson - VP Clinical Reg Affairs at Greenwich LifeSciences, Inc.

Issuer-level insider activity

Role
VP Clinical Reg Affairs
Issuer ticker
GLSI on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jaye Thompson since 15 Aug 2025

Reported holdings for Jaye Thompson in Greenwich LifeSciences, Inc.

Form 4 holding VP Clinical Reg Affairs

Greenwich LifeSciences, Inc.

Security class
Common Stock
Shares / value
264,148
Estimated value
$3,410,151
Report date
21 Nov 2024
Price
$12.91
Ownership
Direct
Form 4 holding VP Clinical Reg Affairs

Greenwich LifeSciences, Inc.

Security class
Stock Options
Shares / value
299,636
Estimated value
Report date
24 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jaye Thompson in Greenwich LifeSciences, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .